PA
About
Australia produces world leading intellectual property in drug development and medical equipment, yet captures virtually none of the downstream commercialisation and job multipliers. This is in part due to underdeveloped domestic preclinical expertise. Proto Axiom on shores this capacity, keeping Australian IP in Australia.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 1,442 investors are based in Sydney, New South Wales, Australia.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Sydney, Australia
Contact Information
Find more investors like Proto
Search Investors